Stem cell therapy itself is not entirely new, but use in MS is still experimental and no therapies have been approved in the United States. There are important ongoing clinical trials in the US and a number of patients have traveled abroad to receive treatment. Patients need to be cautious, however, because of the numerous bogus and unscrupulous “stem cell clinics” who heavily recruit patients for their treatments.
What is cell-based therapy?
“Cell-based therapy” refers to the transplantation, delivery or stimulation of various cell types for the purpose of treating MS. It is important to know that there are a variety of cell-based therapies used in MS. To discuss the state of stem-cell research, more than 70 experts convened a meeting - the International Conference on Cell-Based Therapy for Multiple Sclerosis - held in Lisbon and hosted by the National MS Society, ECTRIMS, and Multiple Sclerosis International Federation (MSIF). Progress was reviewed related to the value of specific cell types, including hematopoietic stems cells (derived from the bone marrow), mesenchymal stem cells (derived from many different adult tissues), and oligodendrocyte precursor cells (derived from multiple sources).
Read this post in its entirety:
Stem Cell Research and MS